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Iron-deficiency anemia (IDA) and lead 
  exposure remain significant public health 
problems. It is estimated that the prevalence of 
IDA is around 46–66% in developing coun-
tries (Stoltzfus et al. 2007). In India, 74% of 
urban children < 3 years of age are anemic 
[International Institute for Population Sciences 
(IIPS) and Macro International 2007].
Although a number of countries have 
recently phased out lead from gasoline, lead 
exposure at the population level in some loca-
tions, particularly in developing countries, 
remains high. Mean blood lead levels are 
reported to be 13 μg/dL in China (Ye et al. 
2007), 15 μg/dL in urban populations in 
Bangladesh (Kaiser et al. 2001; Wasserman 
et al. 2007), and 11 μg/dL among urban chil-
dren in India (Roy et al. 2009a). In contrast, 
developed countries, such as the United States, 
report mean blood lead levels of 1.9 μg/dL 
among children (Jones et al. 2009).
A large body of literature documents the 
adverse effects of lead exposure and iron defi-
ciency on cognitive function among children 
(Canfield et al. 2003; Lanphear et al. 2005; 
Lozoff and Georgieff 2006; McCann and 
Ames 2007). The large variability in effect esti-
mates, between and within study populations, 
could reflect measurement error and residual 
confounding, along with between-person and 
between-population variation in susceptibility, 
due to factors such as genetic polymorphisms. 
Currently, little is known about genetic fac-
tors that may modify the effects of lead and 
iron on children’s neuro  cognition.
Information from experimental and obser-
vational research suggests that genetic polymor-
phisms within the dopamine neurotransmitter 
pathway could influence neurological suscep-
tibility to both lead and IDA. It is well doc-
umented that both iron and lead levels are 
associated with changes in the dopamine sys-
tem, which in turn modulate behavior and cog-
nition (Beard 2007; Beard et al. 2006; Brockel 
and Cory-Slechta 1999; Cory-Slechta 2003; 
Cory-Slechta et al. 1998, 2002; Unger et al. 
2007). Animal studies suggest that autoregula-
tion of the dopamine system via the dopamine 
receptor D2 (DRD2) plays an important role 
in the neurobiological effect of lead and iron 
(Beard and Connor 2003; Cory-Slechta 1995; 
Erikson et al. 2001; Lozoff et al. 2006).
A recent study by Froehlich et al. (2007) 
suggests that the effect of lead on executive 
function among children is modified by dop-
amine D4 receptor genotype, indicating that 
polymorphisms in the dopamine system may 
be important sources of variability in the asso-
ciation between lead and childhood cognition.
The human DRD2 gene is located 
at 11q22-q23. It is associated with TaqI 
  restriction-fragment-length polymorphism 
(Taq IA polymorphism, rs1800497), creating 
A1 and A2 alleles (Wong et al. 2000). Although 
Taq IA is in the ankyrin repeat and protein 
kinase domain containing protein 1 (ANKK1) 
gene, which lies 10,541 bp downstream of the 
termination codon of the DRD2 gene, this 
polymorphism is in strong linkage disequilib-
rium with two other functional DRD2 single-
nucleotide polymorphisms (SNPs; rs2283265 
and rs1076560) that affect DRD2 receptor 
isoform expression (Ponce et al. 2009). Studies 
have shown that healthy individuals who are 
A1 allele carriers have 10–30% lower DRD2 
density and binding in the brain (Jonsson 
et al. 1999; Noble et al. 1991; Pohjalainen 
et al. 1998; Thompson et al. 1997). In addi-
tion, it has been suggested that the A1 allele 
may diminish dopaminergic activity in the 
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Ba c k g r o u n d: Anemia and lead exposure remain significant public health issues in many parts of 
the world, often occurring together. Animal studies suggest that the dopamine D2 receptor (DRD2) 
mediates the effects of both lead and iron on cognition and behavior.
oB j e c t i v e: We tested the hypothesis that the DRD2 Taq IA polymorphism modifies the effects of 
lead and hemoglobin on intelligence quotient (IQ) among children.
Me t h o d s : Blood lead and hemoglobin were assessed in 717 children 3–7 years of age attending 
12 schools in Chennai, India. IQ was determined using the Binet-Kamat scales of intelligence. 
Genotyping for the DRD2 polymorphism was carried out using a MassARRAY iPLEX platform. 
Stratified analyses and interaction models, using generalized estimating equations (GEEs), were 
used to explore interactions between lead and hemoglobin, and DRD2 Taq IA categories [homo-
zygous variant (A1) vs. presence of wild-type allele (A2)].
re s u l t s: After we controlled for potential confounders, a one-unit increase in log blood lead was 
associated with a decrease of 9 IQ points [95% confidence interval (CI), –18.08 to –0.16] in the 
homozygous-variant children (n = 73) compared with a decrease of 4 IQ points (95% CI, –7.21 to 
–0.69) among those with the wild-type allele (n = 644). Higher hemoglobin levels were associated 
with higher IQ in the children who carried the wild-type allele DRD2, but in children homozygous 
for the variant allele, an increase of 1 g/dL hemoglobin was associated with a decrease in 1.82 points 
of IQ (95% CI, –5.28 to 1.64; interaction term p-value = 0.02).
co n c l u s i o n: The results of this study suggest that the DRD2 Taq IA polymorphism disrupts the 
protective effect of hemoglobin on cognition and may increase the susceptibility to the deficits in IQ 
due to lead exposure.
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central nervous system, resulting in prolonged 
P300 latency, which is an event-related poten-
tial recorded by electroencephalographic tech-
niques and associated with cognitive processing 
(Berman et al. 2006) or reduced brain glucose 
metabolism (Noble et al. 1997). In addition, 
the A1 allele has been associated with a multi-
tude of psychiatric disorders (Pacit et al. 2010; 
Ponce et al. 2009), as well as decreased learn-
ing and verbal creativity (Jocham et al. 2009; 
Reuter et al. 2005, 2006), indicating that this 
particular polymorphism may affect dopamine 
mediated behavior and cognition.
Thus, we hypothesized that the effect of 
hemoglobin (as a measure of iron) and lead 
on cognition [intelligence quotient (IQ)] 
among children is modified by the DRD2 
Taq IA polymorphism.
Materials and Methods
Study population and design. The study popu-
lation has been described previously (Roy et al. 
2009a, 2009b). In brief, four different indus-
trial and traffic zones were selected to repre-
sent the range of exposure in Chennai, India. 
Three schools from each of the four zones 
were randomly selected (12 schools total), and 
all 814 children 3–7 years of age from lower 
and upper kindergartens and first grade were 
eligible to be participants in this study.
The parents of the children were invited to 
group discussions with the research team at the 
schools, and informed consent was acquired 
from the primary caregiver of each child. We 
received informed consent from the caregivers 
of all 814 children, but because some children 
were absent or sick on the day of blood draw, 
only 756 (92.8%) participated in the study.
The study was cross-sectional, with cogni-
tive testing and blood collection for lead and 
genotype analyses done on the same day. A 
trained interviewer orally administered a ques-
tionnaire in Tamil (the regional language) to 
the primary caregiver of the child to collect 
information on other covariates.
This collaborative study on lead genet-
ics and neurotoxicity was conducted by the 
Harvard School of Public Health (HSPH; 
Boston, MA, USA) and Sri Ramachandra 
Medical College and Research Institute 
(SRMC; Chennai, India). The study was 
approved by institutional review boards at 
HSPH, University of Michigan School of 
Public Health, SRMC, and the Indian 
Council for Medical Research (New Delhi, 
India) and complied with all federal U.S. and 
Indian regulations and laws regarding research 
in human subjects.
Assessment of cognitive function. The IQ 
of each child (n = 756) was derived using the 
standardized Tamil-translated Binet-Kamat 
Scales of Intelligence (Kamat 1967), which 
was administered in a separate quiet room 
on the school premises by trained research 
personnel who were blinded to all aspects 
of the children’s lead exposure and develop-
mental history. This amended and validated 
version of the 1934 Stanford-Binet Scales of 
Intelligence is a culture-specific scale that uses 
Indian pictorial scenes and concepts. The test 
is designed to measure aptitude and intel-
lectual capacity through assessment of ver-
bal reasoning, comprehension, quantitative 
reasoning, vocabulary, abstract reasoning, 
similarities, differences, visual reasoning, and 
short-term memory. The child’s mental age 
(in months) was calculated based on his or 
her performance on the Binet-Kamath IQ 
Test. The mental age was then divided by the 
chronological age (in months) and multiplied 
by 100 to obtain the child’s IQ.
Assessment of blood lead and hemoglobin. 
Whole blood (10 mL) was collected from the 
cubital vein of each child into lead-free tubes 
(Becton-Dickinson blue-top tubes; Becton-
Dickinson, Franklin Lakes, NJ USA) by a 
trained phlebotomist during a school day.
Blood lead was measured at SRMC, 
using a LeadCare Analyzer instrument (ESA 
Laboratories, Chelmsford, MA, USA), which 
is a well-validated field instrument with limit 
of detection of 1.4 μg/dL blood lead, range of 
1.4–65 μg/dL, and resolution of 0.1 μg/dL 
(Shannon and Rifai 1997). Duplicates and 
ESA company controls were run every 20 
samples and with every new batch and kit lot. 
The instrument was calibrated every time a 
new test kit batch or control batch was used.
Blood hemoglobin concentrations (grams 
per deciliter) were measured using standard 
clinical methods on a BC-3000 Plus Auto 
Hematology Analyzer (MINDRAY; Bio-
Medical Electronics Co., Ltd., Shenzhen, 
China) at the Pathology and Hematology 
Laboratory in SRMC. The auto analyzer 
has a range of 1–25 g/dL for hemoglobin. 
Hemoglobin levels were missing, due to labo-
ratory error, for three study participants.
Genotyping. DNA was extracted from an 
aliquot of the collected blood of each child 
and analyzed for the DRD2 Taq IA (A1, A2) 
allele SNP (rs1800497; SNP500Cancer ID 
ANKK1-01). The sequence, including 600 
bp upstream and downstream of the SNP, 
was ascertained from Genewindow (http://
genewindow.nci.nih.gov/Welcome). All 
polymerase chain reaction (PCR) and exten-
sion primers were synthesized at BioServe 
Biotechnologies, Ltd. (Beltsville, MD, USA). 
Genotyping was performed by BioServe at 
their Hyderabad, India, facility using a 
MassARRAY iPLEX platform (Sequenom, 
San Diego, CA, USA), which is a PCR pro-
cess and mass spectrometry–based system.
To ensure that the samples were pro-
cessed correctly and without external con-
tamination, quality control checks involved 
four positive controls for each assay and four 
negative controls (no template controls) per 
plate. The positive controls were 24 DNA 
samples, in duplicate from the National 
Institutes of Health Polymorphism Discovery 
Panel (Collins et al. 1999). They were 
selected to cover all the possible genotypes 
available for the multiplex assay panel devel-
oped. The peaks for individual assays were 
checked manually in addition to Sequenom’s 
SpectroTYPER software automated detection.
The full data set was anonymized after 
genotyping to protect the confidentiality of 
our study participants and to conform to cur-
rent institutional review board policies.
Statistical analysis. The genotype frequen-
cies were calculated, and the observed frequen-
cies were tested against expected frequencies 
according to Hardy–Weinberg equilibrium 
principles using the chi-square statistic.
Univariate distributions of all variables of 
interest were explored across DRD2 polymor-
phism type. Blood lead levels were natural log 
transformed to maintain a normal distribu-
tion. Bivariate analysis of variance tests were 
conducted to ascertain if the distributions of 
covariates differed among the DRD2 Taq IA 
genotypes. In all multivariate analyses, outliers 
in lead (n = 7) and IQ (n = 1) identified using 
the generalized extreme studentized deviate 
method were removed (Rosner 1983).
We built multivariate models using ordi-
nary least squares regression to estimate asso-
ciations between IQ and blood lead and/or 
hemoglobin. Covariates [age + age2 (months), 
sex, midarm circumference (centimeters), 
average monthly family income (< 2,000, 
2,000–4,000, 4,000–6,500, > 6,500 Indian 
rupees), and family size] were retained in the 
regression model if they changed the R2 and/
or main effect estimate by > 10%. Parental 
education (both mother and father: illiterate/
primary school, middle school, high school, 
college) was included in the multivariate 
model in order to maintain consistency with 
other studies that evaluated the impact of lead 
and hemoglobin on cognition.
Because the study used a multilevel sam-
pling system, correlation among levels of 
sampling (classroom, school, and zone) were 
calculated using intraclass correlations in a 
random effects model. Because the distribu-
tions of the residuals were not strictly nor-
mal, we used generalized estimating equations 
(GEEs), which use quasi-likelihood meth-
ods to model the marginal associations after 
accounting for clustering at the classroom and 
school level (Qaqish and Liang 1992).
Our first step was to create a multivariate 
main effects model to estimate the effects of 
lead, hemoglobin, and DRD2 Taq IA geno-
types [categorized as A1/A1, A1/A2, or A2/A2 
(referent)] on IQ, adjusted for age (age and 
age2, in months), sex, midarm circumference 
(centimeters), average monthly family income Roy et al.
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(four categories), parental education (mother 
and father: illiterate/primary school, middle 
school, high school, college), and family size 
(model 1). Next we estimated effects of lead 
and hemoglobin on IQ according to geno-
type (three categories) using stratified models 
adjusted for the covariates above (model 2).
We then combined the DRD2 Taq IA 
allele categories into two categories (A1/A1 
vs. A1/A2 and A2/A2 combined). In model 3, 
we estimated the effects of lead and hemoglo-
bin on IQ stratified across these categories, 
and in model 4 we evaluated the interaction 
between lead and DRD2 Taq IA polymor-
phism and hemoglobin and DRD2 Taq IA 
polymorphism. The interaction terms (hemo-
globin × DRD2 Taq IA category and lead × 
DRD2 Taq IA category) were modeled first in 
separate models, while adjusting for the other 
exposure and then jointly, to assess joint inter-
actions, after controlling for all other potential 
confounders. A three-way interaction (hemo-
globin × lead × DRD2 Taq IA category) was 
not assessed because no interaction between 
lead and hemoglobin was seen.
To assess the dose–response relationship 
between hemoglobin/lead and IQ within the 
DRD2 Taq IA genotype categories, penalized 
splines in generalized additive mixed mod-
els, accounting for cluster design, were used 
(Wood 2006). When nonlinearity was pres-
ent, the penalized spline model was compared 
with the linear model using Akaike’s informa-
tion criterion and generalized cross-validation.
The α-level for all statistical tests of sig-
nificance was set at 5%. Statistical analyses 
were performed using SAS for Windows, ver-
sion 9.2 (SAS Institute Inc., Cary, NC, USA) 
and R version 2.5.1 (R Project for Statistical 
Computing, Vienna, Austria).
Results
Thirty-one of the 756 children in the study 
(~ 4%) had missing genotype information. Of 
the 725 children (53% male and 47% female) 
we genotyped, 74 (10.2%) were homozygous 
and 293 (40.4%) were heterozygous for the 
variant DRD2 Taq IA allele (A1). The dis-
tribution of the variant allele was in accor-
dance with the Hardy–Weinberg equilibrium 
(χ2 = 1.4821; p-value > 0.05).
The prevalence of anemia (hemoglobin 
< 11 g/dL) was 25%. The mean (± SD) blood 
lead, hemoglobin, and IQ, respectively, were 
11.5 ± 5.3 μg/dL (range, 2.6–40.5 μg/dL), 
11.8 ± 1.2 g/dL (range, 5.2–16.9 g/dL), and 
107 ± 17 points (range, 42–166 points), 
and we found no significant differences by 
DRD2 Taq IA genotype. Children who were 
homozygous variant had a higher number of 
siblings (p-value = 0.04), but other factors 
did not vary between homozygous variant 
and combined heterozygous and homozygous 
wild-type genotypes (Table 1).
After removal of outliers (lead and IQ: 
n = 8), 717 children remained in the study. 
The adjusted multivariate main effects GEE 
model (Table 2, model 1) indicated an inverse 
association between lead and IQ [–4.22 
points; 95% confidence interval (CI), –7.10 to 
–1.36; for each one-unit increase in log blood 
lead (micrograms per deciliter)] and a posi-
tive association between hemoglobin and IQ 
(2.30 points; 95% CI, 1.26–3.08; for a 1-g/
dL increase in hemoglobin). We observed no 
significant interaction between lead and hemo-
globin (p = 0.39). DRD2 Taq IA genotype was 
not a significant predictor of IQ. Children 
carrying the homozygous and heterozygous 
variant alleles had IQs 0.87 points lower (95% 
CI, –4.3576 to 2.6109) and 0.13 points lower 
(95% CI, –2.2122 to 1.9437), respectively, 
than children who were homozygous for the 
wild-type DRD2 Taq IA allele.
In the models stratified by three-category 
genotype (Table 2, model 2), the inverse asso-
ciation between lead and IQ was stronger 
among children who carried the homozygous 
variant genotype than among children who 
carried the heterozygous or homozygous wild-
type genotype. Increasing hemoglobin lev-
els were associated with increasing IQ points 
among the children who were heterozygous 
(β estimate = 2.24; 95% CI, 0.57–3.91) 
and homozygous (β estimate = 3.03; 95% 
CI, 1.60–4.45) for the wild-type allele but 
Table 1. Child and family characteristics by DRD2 genotype.
Variable
Taq A1/A1  
(n = 74)
Taq A1/A2 + A2/A2   
(n = 651)
Child characteristics (mean ± SD)
IQ 106.62 ± 17.34 107.32 ± 16.91
Blood lead (μg/dL) 11.66 ± 5.11 11.42 ± 5.43
Hemoglobin (g/dL) 11.95 ± 1.14 11.91 ± 1.19
Midarm circumference (cm) 16 ± 1.61 16.05 ± 1.48
Age (years) 5.05 ± 0.95 4.95 ± 0.93
Family characteristics [n (%)]
Average monthly income (Indian rupees)
< 2,000 12 (16.22) 97 (14.9)
2,000–4,000 30 (40.54) 291 (44.7)
4,000–6,500 19 (25.68) 157 (24.12)
> 6,500 13 (17.57) 106 (16.28)
Mother’s education level
Illiterate/primary school 15 (20.27) 118 (18.13)
Middle school completion 23 (31.08) 224 (34.41)
High school certificate 22 (29.73) 152 (23.35)
College 14 (18.92) 157 (24.12)
Father’s education level
Illiterate/primary school 11 (14.86) 76 (11.67)
Middle school completion 16 (21.62) 187 (28.73)
High school certificate 22 (29.73) 184 (28.26)
College 25 (33.78) 204 (31.34)
No. of other children
0 12 (16.22) 148 (22.89)
1 47 (63.51) 419 (64.36)
≥ 2 15 (20.27) 84 (12.90)
Table 2. Effect of lead and hemoglobin on IQ by DRD2 Taq IA genotype: results from stratified and interaction multivariate GEE models.a
Lead [ln (μg/dL)] Hemoglobin (g/dL)
Model Genotype n β-Coefficient (95% CI) p-Value β-Coefficient (95% CI) p-Value
1: Main effects model Combined 717 –4.22 (–7.10 to –1.36) 0.004 2.30 (1.26 to 3.08) < 0.0001
2: Stratified model A1/A1 73 –9.12 (–18.08 to –0.16) 0.047 –1.82 (–5.28 to 1.64) 0.306
A1/A2 290 –4.35 (–8.24 to –0.44) 0.023 2.24 (0.57 to 3.91) 0.001
A2/A2 354 –3.87 (–8.28 to 0.54) 0.009 3.03 (1.60 to 4.45) < 0.0001
3: Stratified model A1/A1 73 –9.12 (–18.08 to –0.16) 0.046 –1.82 (–5.28 to 1.64) 0.302
A1/A2 + A2/A2 644 –4.00 (–7.21 to –0.69) 0.017 2.72 (1.58 to 3.86) < 0.0001
4: Interaction modelb A1/A1 717 –7.27 (–17.53 to –0.20) > 0.28c –1.32 (–4.66 to 2.02) 0.022c
A1/A2 + A2/A2 –3.94 (–7.10 to –0.79) 2.72 (1.60 to 3.84)
aControlling for midarm circumference, age, sex, family income, parental education, and family size and accounting for school and classroom levels. bThe model assessing the inter-
action of lead and DRD2 Taq IA controlled for confounding by hemoglobin and vice versa for the model assessing hemoglobin and DRD2 Taq IA interaction. cp-Values for interaction 
term coefficients.Lead exposure, hemoglobin, DRD2 polymorphism, and IQ in India
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was inversely associated with IQ among those 
homozygous for the variant allele (β estimate 
= –1.82; 95% CI, –5.28 to 1.64). Also, the 
magnitude and direction of the associations 
between lead and IQ and between hemoglo-
bin and IQ were similar in the children who 
were heterozygous and homozygous wild-type 
for the DRD2 Taq IA polymorphisms.
This suggested a recessive expression of the 
genotype, which we modeled by creating cat-
egories of DRD2 Taq IA variant homozygous 
(A1/A1, n = 74) versus not Taq IA variant 
homozygous (carrying the wild type: A1/A2 + 
A2/A2; n = 651).
In the subpopulation carrying the 
DRD2 Taq IA variant homozygote geno-
type (model 3), a unit increase in log blood 
lead (micrograms per deciliter) resulted in a 
decrease of 9.1 IQ points (95% CI, –18.08 
to –0.16) compared with a decrease of 4.0 IQ 
points (95% CI, –7.21 to –0.69) among those 
who carried the wild-type genotype even after 
controlling for all other covariates. However, 
this difference in estimated effects of lead on 
IQ across the different DRD2 Taq IA catego-
ries was not statistically significant (p > 0.1) 
in the interaction model (model 4), when 
modeled with and without the hemoglobin × 
DRD2 term.
In contrast, the association between hemo-
globin and IQ was consistently different in the 
DRD2 polymorphism subgroups and in the 
interaction model. Higher hemoglobin was 
associated with an increase of 2.7 points of IQ 
among children with the wild-type alleles and 
was significant even after controlling for lead, 
midarm circumference, age, sex, parental edu-
cation, family income, and number of children 
in the family unit (p < 0.0001). Among the 
homozygous variant children, a unit increase 
in hemoglobin was associated with a decrease 
of 1.8 points in IQ (i.e., the effect changed 
direction), but this was not statistically signifi-
cant in this stratum (model 3). From the inter-
action model including the cross product term 
(hemoglobin × homozygous variant), a unit 
increase in hemoglobin was associated with 1.3 
IQ points decrease (p = 0.02), after controlling 
for other variables (model 4). The shape of the 
dose–response relationship between hemo-
globin and IQ in the different DRD2 Taq IA 
genotype categories was linear.
Discussion
Higher hemoglobin was associated with 
higher IQ in our study population and, in 
particular, among those children who are car-
riers of the wild-type allele (A2) of the DRD2 
Taq IA polymorphism. This is consistent with 
the findings from other studies. A meta-anal-
ysis of studies from Europe, North and South 
America, and the Middle East reported that a 
decrease of 1 g/dL hemoglobin was associated 
with a decrease in 1.73 IQ points (95% CI, 
1.04–2.41) (Stoltzfus et al. 2007). Our find-
ing of a decrease in 2.30 IQ points per 1-g/dL 
decrease of hemoglobin is consistent with the 
range of effect estimates reported.
However, this association did not hold 
among homozygous variant (A1) children, for 
whom increasing hemoglobin levels were asso-
ciated with a decrease of 1.82 IQ points. This 
represents a reversal of the effect across the 
polymorphism and suggests that this genetic 
subgroup may have less potential for neuro-
protective effects by iron supplementation.
Importantly, this points toward the role 
DRD2 Taq IA polymorphism plays in modi-
fying the effect of hemoglobin on cognition. 
In animal studies, iron levels are associated 
with changes in the dopamine system (Beard 
and Connor 2003; Unger et al. 2007). A 
study in iron-deficient rodents by Erikson 
et al. (2000) found that dopamine D2 recep-
tor density in the nucleus accumbens and the 
ventral midbrain was reduced and associated 
with decreased D2 receptor–mediated activity. 
In their model of iron deficiency, they noted a 
decrease in the dopamine transporter (DAT) 
functioning, both in vitro and in vivo. They 
also detected a positive correlation between 
DRD2 and DAT density and hypothesized 
that the iron deficiency–induced reduction 
in DRD2 presynaptic receptors, which are 
involved in negative-feedback regulation of 
the dopamine system through increased DAT 
density and clearance of dopamine from the 
synapse (Dickinson et al. 1999; Meiergerd 
et al. 1993) and therefore may be responsible 
for the reduced DAT activity and density. 
Thus, decreased dopamine D2 receptor den-
sity along with iron deficiency, as noted by 
other studies (e.g., Youdim et al. 1989) may 
affect this regulatory pathway and affect dop-
amine neural signaling and associated behav-
ior and cognition.
The mild adverse effect noted among 
homozygous variants could reflect a true 
adverse effect of hemoglobin on IQ; however, 
it may be an artifact due to the small number 
of children in this group, as evidenced by the 
wide variability in the effect estimate.
Even though we did not see a significant 
interaction between lead and DRD2 geno-
type, the steep decrease in IQ associated with 
increasing blood lead among the children 
homozygous for the variant in the DRD2 
Taq IA allele suggests that these children may 
be more susceptible to the effects of lead on 
cognition. This is consistent with previous 
studies on lead and dopamine neurotrans-
mission. A recent study by Froehlich et al 
(2007) suggests that the effect of lead on exec-
utive function among children is modified 
by a variable number of tandem repeats in 
the dopamine D4 receptor gene, indicating 
that polymorphisms in the dopamine system 
may be important sources of variability in 
the association between lead and childhood 
cognition.
In animal studies, lead has been shown to 
alter dopamine release, turnover, and recep-
tor density (Cory-Slechta 1995, 1996, 1997; 
Zuch et al. 1998). Lead treatment is reported 
to cause differential and/or opposing effects 
on the nigrostriatal and mesolimbic dopamine 
systems. A study by Govoni et al. (1986) 
reported increased D2 binding in striatum 
but decreased binding in nucleus accumbens 
after lead exposure. However, in an autoradio-
graphic study, chronic postweaning lead expo-
sure was associated with decreased D1, D2, 
and DAT binding in the nucleus accumbens 
but not in the striatum (Pokora et al. 1996).
Much of the evidence of the role of the 
dopamine system in lead-induced neurocog-
nitive impairments comes from animal stud-
ies that used fixed-interval schedule controlled 
behavior protocols, in which animals were 
repeatedly rewarded following scheduled time 
intervals of varying length for a specific behav-
ior. In children ranging from 3 months to 
9 years of age, response rates on fixed-interval 
schedules have been asserted to be a marker 
for impulsivity (Darcheville et al. 1993).
Environmentally relevant exposure levels 
of lead have repeatedly been shown to increase 
fixed-interval response rates, in some studies 
as much as 300% more than rates in con-
trol animals (Cory-Slechta et al. 1998, 2002). 
This may be attributable to increased nucleus 
accumbens dopamine levels, which are associ-
ated with increased fixed-interval responses. 
Mice exposed to lead and then administered 
dopamine agonists and antagonists showed 
markedly different fixed-interval responses. 
The study also suggested that lead-exposed 
mice had lower dopamine receptor (including 
DRD2) production, as demonstrated by the 
difference in recovery rates after being exposed 
to an irreversible antagonist (Cory-Slechta 
et al. 1998). There is evidence of enhanced 
sensitivity of D2 autoreceptors to alterations 
by lead (Zuch et al. 1998). This lends credence 
to the hypothesis that lead alters autoregula-
tion of the dopamine system through DAT 
and presynaptic D2 receptors, which cause 
changes in baseline extracellular dopamine 
  levels and downregulation of postsynaptic 
dopamine receptors (Cory-Slechta 1995).
Although there is considerable variation in 
the reports of how lead affects the dopamin-
ergic system in different areas of the brain, 
there seems to be sufficient information to 
say that lead alters dopamine neurotransmis-
sion and that autoregulatory D2 receptors 
play an important role. Thus, it is biologically 
plausible that the findings of our study reflect 
the effect of lead on dopamine, which in turn 
regulates behavior and cognition.
Ours is the first epidemiological study to 
examine the role of a dopamine D2 receptor Roy et al.
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polymorphism in relation to the effects of lead 
exposure and hemoglobin on IQ and is also 
the first study to document the distribution of 
the DRD2 Taq IA alleles in an Indian popula-
tion. Although we studied 717 children, it is 
possible that the study was still underpowered 
to detect modification of the effect of lead on 
IQ, because the subpopulation of homozygous 
variant children accounted for only 10% of 
the population (n = 73). Further studies with 
larger sample sizes may be needed to determine 
if such a gene–environment interaction exists.
This study has several limitations. The 
cross-sectional observational design does not 
allow us to determine temporal or causal 
associations between lead/hemoglobin and 
cognition. The modification of these effects 
by genotype is, however, unaffected by the 
design. We also note that for both lead and 
hemoglobin, multiple prospective studies 
have demonstrated that exposures (high lead 
and low iron status) precede the decrease in 
neurological functions tested, and these asso-
ciations are widely accepted.
We did not assess the quantity or quality 
of emotional and cognitive stimulation in the 
home environment using an instrument, such 
as the Home Observation for Measurement 
of the Environment Inventory, because a 
similar instrument that is culturally appropri-
ate for the Indian subcontext does not exist. 
However, we did control for socioeconomic 
status (income, family size) and parental edu-
cation, which have been shown to be moder-
ately correlated with the stimulation provided 
to a child in the home (Seifer 2001).
The instruments used to measure blood 
lead and hemoglobin levels have been docu-
mented to have good field accuracy and preci-
sion, reducing the likelihood that substantial 
measurement error is present. Selection bias 
in this study is unlikely because 93% of the 
enrolled subjects participated in the full study 
and, moreover, comparison of the descriptive 
characteristics of those who provided blood 
samples and those who did not did not show 
any marked differences.
The findings of this study have important 
implications for developing countries, such as 
India, which have a high burden of anemia 
and elevated lead exposure among children. 
The most recent National Family Health 
Survey (2005–2006) estimated that 79% 
of all children 6–35 months of age in India 
are anemic (IIPS and Macro International 
2007). In 1998–1999, approximately 45% 
and 50% of children < 3 years old in Delhi 
and Mumbai, respectively, had blood lead 
levels > 10 μg/dL (which is the level of con-
cern by U.S. Centers for Disease Control and 
Prevention 1997) (Jain and Hu 2006). Lead 
was phased out of gasoline in India in 2000; 
however, childhood lead exposures continue 
to be elevated: Mean blood lead levels recently 
reported in children from urban areas range 
from 7.4 to 18.0 μg/dL (Ahamed et al. 2005, 
2007; Nichani et al. 2006; Zimmermann 
et al. 2006). Our findings suggest that within 
such populations, children with the DRD2 
Taq IA genetic polymorphism may be bear-
ing the greater burden of lead-associated IQ 
impairment. More important, they also may 
not benefit and, in fact, may suffer adverse 
effects from iron supplementation. Hence, 
the findings of this study are provocative and 
warrant further research.
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